Sp. Anderson et al., Hepatic expression of acute-phase protein genes during carcinogenesis induced by peroxisome proliferators, MOL CARCINO, 26(4), 1999, pp. 226-238
Concern exists regarding peroxisome proliferator (PP) xenobiotic exposure b
ecause many PPs are potent hepatocarcinogens in rodents. The mechanism of c
arcinogenicity induced by PPs is atypical compared with those of other hepa
tocarcinogens in that the former appears to involve alterations in expressi
on of PP-activated receptor (PPAR) target genes rather than direct mutageni
city. To begin to identify some of these genes, we used differential displa
y to compare mRNA expression between hepatic adenomas and adjacent non-tumo
r liver from rats fed the potent PP Wy-14643 (WY) for 78 wk. Here, we repor
t increased expression of the acute-phase protein (APP) gene alpha-1 antitr
ypsin (AT) and decreased expression of alpha 2-urinary globulin in the tumo
rs. Similar changes were seen in hepatic adenomas induced by a diethylnitro
samine and phenobarbital protocol, indicating a lack of specificity for PP-
induced tumors. Additional APP genes, including ceruloplasmin, haptoglobin,
beta-fibrinogen, and ctl-acid glycoprotein were also upregulated in WY-ind
uced tumors but were downregulated in the livers of rats administered a dif
ferent PP for 13 wk. Mice treated with either WY or di(2-ethylhexyl) phthal
ate for 3 wk had decreased hepatic AT expression but increased expression o
f ceruloplasmin and haptoglobin. PPAR alpha-null mice showed no hepatic APP
gene alteration after PP treatment but had higher basal expression than di
d wild-type controls. We conclude that PPAR alpha activation by several dif
ferent PPs leads to dysregulation of hepatic APP gene expression in rats an
d mice. This dysregulation may indicate alterations in cytokine signaling n
etworks regulating both APP gene expression and hepatocellular proliferatio
n. Mel. Carcinog. 26:226-238, 1999. (C) 1999 Wiley-Liss, Inc.